References
- Alter MJ, Margotis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327(27): 1899–905
- Wilson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92(1): 3–17
- Doutrelepont JM, Alder M, Willems M, et al. Hepatitis C infection and membranoproliferative glomerulonephritis. (Letter) Lancet 1993; 341(8840): 317
- Harle JR, Disdier P, Dussol B, et al. Membra-noproliferative glomerulonephritis and hepatitis C infection. (Letter) Lancet 1993; 341 (8849): 904
- D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54(2): 650–71
- D'Amico G, Colasanti G, Ferrario F. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989; 35(4): 1004–14
- Yamabe H, Johnson RJ, Gretch DR, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6(2): 220–3
- Garcia-Valdecasas J, Bernal C, Garcia F, et al. Epidemiology of hepatitis C virus infection in patients with renal disease. J Am Soc Nephrol 1994; 5(2): 186–92
- Johnson RJ, Wilson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994: 46(5): 1255–63
- Jefferson JA, Johnson RJ. Treatment of hepatitis C-associated glomerular disease. Semin Nephrol 2000; 20(3): 286–92
- D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995; 25(3): 361–9
- Tarantino A, De Vecchi A, Montagnino G, et al. Renal disease in essential mixed cryoglobulinaemia: long-term follow-up of 44 patients. Q J Med 1981; 50(197): 1–30
- Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47(2): 618–23
- Muller HM, Pfaff E, Goeser T, et al. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993; 74(Pt 4): 669–76
- Campise M, Tarantino A. Glomerulonephritis in mixed cryoglobulinaemia: What treatment? Nephrol Dial Transplant 1999; 14(2): 281–3
- Bojic I, Lilie D, Radojcic C, et al. Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a. J Gastroenterol 1994; 29(3): 369–71
- Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330(11): 751–6
- Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis: effect of alfa-interferon therapy. Kidney Int 1994; 46(6): 1700–4
- Sarac E, Bastacky S, Johnson JP. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection. Am J Kidney Dis 1997; 30(1): 113–5
- Misiani R, Bellavita P, Baio P, et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant 1999; 14(6): 1558–60
References
- Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327(21): 1490–5
- Alter MJ, Marzolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A. non-B Hepatitis Study Team. N Engl J Med 1992; 327(27): 1899–905
- Wilson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92(1): 3–17